Back
Allegiant Travel 10K Form
Sell
34
ALGT
Allegiant Travel
Last Price:
102.82
Seasonality Move:
-2.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-03-01 | 10K | ALGT/Allegiant Travel Annual |
2020-08-04 | 10Q | ALGT/Allegiant Travel Quarterly |
2020-05-22 | 10Q | ALGT/Allegiant Travel Quarterly |
2020-02-27 | 10K | ALGT/Allegiant Travel Annual |
2019-10-31 | 10Q | ALGT/Allegiant Travel Quarterly |
2019-07-31 | 10Q | ALGT/Allegiant Travel Quarterly |
Receive ALGT News And Ratings
See the #1 stock for the next 7 days that we like better than ALGT
ALGT Financial Statistics
Sales & Book Value
Annual Sales: | $2.3B |
---|---|
Cash Flow: | $85.52M |
Price / Cash Flow: | 0 |
Annual Sales: | $70.64 |
Price / Book: | 1.52 |
Profitability
EPS (TTM): | 3.62000 |
---|---|
Net Income (TTM): | $66.52M |
Gross Margin: | $340.47M |
Return on Equity: | 5.42% |
Return on Assets: | 1.49% |
Allegiant Travel Earnings Forecast
Key Allegiant Travel Financial Ratios
- The Gross Profit Margin over the past 19 years for ALGT is 14.79%.
- The Selling, General & Administrative Expenses for ALGT have been equal to 4.37% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 4,139.36% of Operating Income.
- The Net Earning history of ALGT is 0.11% of Total Revenues.
- Per Share Earnings over the last 21 years have been positive in 12 years.
Allegiant Travel Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Airlines |
Sector: | Industrials |
Current Symbol: | ALGT |
CUSIP: | 01748X |
Website: | allegiant.com |
Debt
Debt-to-Equity Ratio: | 1.66 |
---|---|
Current Ratio: | 1.16 |
Quick Ratio: | 0.95 |
Price-to-Earnings
Trailing P/E Ratio: | 747.79 |
---|---|
Forward P/E Ratio: | 9.19 |
ALGT Technical Analysis vs Fundamental Analysis
Sell
34
Allegiant Travel (ALGT)
is a Sell
Is Allegiant Travel a Buy or a Sell?
-
Allegiant Travel stock is rated a Sell
The current Allegiant Travel [ALGT] share price is $104.69. The Score for ALGT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.